DBV Ownership | Who Owns DBV?
DBV Ownership Summary
DBV is owned by 0.26% institutional investors, and 99.74% retail investors. Nbc securities is the largest institutional shareholder, holding 0% of DBVT shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.02% of its assets in DBV shares.
DBVT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | DBV | 0.26% | - | 99.74% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Nbc securities | - | - | - |
Commodore capital lp | - | - | - |
Point72 asset management | - | - | - |
Federation des caisses desjardins du quebec | - | - | - |
Barclays | - | - | - |
Optiver b.v. | - | - | - |
Advisor group | - | - | - |
Bank of america corp /de/ | - | - | - |
Boxer capital | - | - | - |
Geode capital management | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Nbc securities | - | - | - |
Commodore capital lp | - | - | - |
Point72 asset management | - | - | - |
Federation des caisses desjardins du quebec | - | - | - |
Barclays | - | - | - |
Optiver b.v. | - | - | - |
Advisor group | - | - | - |
Bank of america corp /de/ | - | - | - |
Boxer capital | - | - | - |
Geode capital management | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Optiver b.v. | - | - | -6.00 |
Advisor group | - | - | -117.00 |
Jpmorgan chase | - | - | -200.00 |
Mark sheptoff financial planning | - | - | -300.00 |
Bank of america corp /de/ | - | - | -1.23K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Baker bros. advisors lp | - | - | -14.61M |
Braidwell lp | - | - | -7.84M |
Yiheng capital management | - | - | -5.57M |
Point72 asset management | - | - | -3.11M |
Vivo capital | - | - | -2.71M |
Sold Out
Holder | Change |
---|---|
Optiver b.v. | -6.00 |
Advisor group | -117.00 |
Jpmorgan chase | -200.00 |
Mark sheptoff financial planning | -300.00 |
Bank of america corp /de/ | -1.23K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 2 | -93.75% | 250,117 | -99.34% | - | 0.07% | - | -100.00% | 2 | -77.78% |
Mar 31, 2024 | 32 | -15.79% | 37,683,193 | -0.01% | 19 | 1.29% | 6 | -66.67% | 9 | 50.00% |
Dec 31, 2023 | 38 | 5.56% | 37,687,441 | -15.07% | 39 | 7.09% | 18 | 63.64% | 6 | -14.29% |
Sep 30, 2023 | 36 | 2.86% | 44,376,498 | -3.52% | 23 | 3.93% | 11 | -8.33% | 7 | 75.00% |
Jun 30, 2023 | 35 | 9.38% | 45,997,904 | 8.94% | 24 | 4.85% | 12 | 140.00% | 4 | -55.56% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Nasdaq Composite Index | 19.39K | 0.02% | - |
Comerica Foreign Equity CIT - Inst Class | 777.00 | 0.00% | - |
LUX IM Global Medtech HX | 32.00 | - | -50.50K |
ActivePassive International Equity ETF | 2.00 | - | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 22, 2024 | Mohideen Pharis | Chief Medical Officer | Sell | $181.26 |
Nov 25, 2024 | Mohideen Pharis | Chief Medical Officer | Sell | $322.05 |
Nov 21, 2024 | Mohideen Pharis | Chief Medical Officer | Sell | $1.27K |
Jul 29, 2024 | Mohideen Pharis | Chief Medical Officer | Sell | $1.75K |
May 24, 2024 | Mohideen Pharis | Chief Medical Officer | Sell | $897.60 |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 3 |
2024 Q3 | - | 1 |
2024 Q2 | - | 2 |
2024 Q1 | 2 | - |
2023 Q4 | - | 1 |
DBVT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools